TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Adesso Bioproducts AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,623
|
10,010
|
7,518 |
| Financial expenses |
96
|
57
|
36 |
| Earnings before taxes |
429
|
635
|
507 |
| Total assets |
5,899
|
7,660
|
8,140 |
| Current assets |
4,429
|
6,128
|
6,449 |
| Current liabilities |
2,135
|
3,991
|
4,782 |
| Equity capital |
3,701
|
3,595
|
3,273 |
| - share capital |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.7%
|
46.9%
|
40.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.6%
|
6.3%
|
6.7% |
| Return on assets (ROA) |
8.9%
|
9.0%
|
6.7% |
| Current ratio |
207.4%
|
153.5%
|
134.9% |
| Return on equity (ROE) |
11.6%
|
17.7%
|
15.5% |
| Change turnover |
-1,751
|
2,887
|
1,584 |
| Change turnover % |
-19%
|
41%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.